Search results for "Highlights"
No differences found in effects of secondary diabetes drugs on kidney outcomes
A trial found similar rates of progression to kidney disease among patients with type 2 diabetes who were randomized to add a sulfonylurea, a dipeptidyl peptidase-4 inhibitor, a glucagon-like peptide-1 receptor agonist, or basal insulin to metformin treatment.
https://diabetes.acponline.org/archives/2023/06/09/1.htm
9 Jun 2023
Whole, plant-based diet most effective for type 2 diabetes remission, ACLM says
Diet as a primary intervention can achieve remission for many with type 2 diabetes and should focus on plant-based foods with minimal consumption of meat and other animal products, according to a statement from the American College of Lifestyle Medicine (ACLM).
https://diabetes.acponline.org/archives/2022/06/10/3.htm
10 Jun 2022
Cystatin C levels associated with risk of sight-threatening diabetic retinopathy
The biomarker may be useful for predicting this condition, especially in areas that don't have access to retinal imaging, according to an analysis of ophthalmology patients in the United Kingdom and India.
https://diabetes.acponline.org/archives/2022/05/13/3.htm
13 May 2022
Unrecognized risk factors for severe hypoglycemia outlined in insulin-treated type 2 diabetes
An industry-funded case-control study of data from a U.S. administrative claims database found that pregnancy, alcohol misuse, short or rapid-acting insulin, and smoking, among other conditions and medications, were independently associated with increased risk.
https://diabetes.acponline.org/archives/2022/04/08/3.htm
8 Apr 2022
Guaranteeing adequate carbs before postpartum oral glucose tolerance testing may not be necessary
An analysis of data from two prospective studies found no relationship between carbohydrate intake in the day or days before testing and glucose level 120 minutes after oral glucose tolerance testing.
https://diabetes.acponline.org/archives/2023/05/12/1.htm
12 May 2023
Interventions uncommon for prediabetes in primary care
A U.S. retrospective study found that while 63.4% of prediabetes patients had repeated glycemic testing over one year of follow-up, 10.4% had a primary care visit with a coded diagnosis of prediabetes, 1.0% were referred for nutrition services, and 5.4% were prescribed metformin.
https://diabetes.acponline.org/archives/2022/03/11/2.htm
11 Mar 2022
Recent articles address federal diabetes programs, type 1 diabetes care
The National Clinical Care Commission made 39 recommendations for improving federal diabetes programs, and the latest In the Clinic article offered advice on diagnosing and treating type 1 diabetes.
https://diabetes.acponline.org/archives/2022/03/11/6.htm
11 Mar 2022
SGLT-2 inhibitors reduce cardiac events, mortality compared to DPP-4 inhibitors
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors were associated with lower risk of cardiovascular events compared to dipeptidyl peptidase-4 (DPP-4) inhibitors but higher risk of genital infections and diabetic ketoacidosis, a retrospective study found.
https://diabetes.acponline.org/archives/2023/02/10/1.htm
10 Feb 2023
Nearly one-third of patients were nonadherent to newly prescribed SGLT-2 inhibitors, GLP-1 receptor agonists
Factors associated with not filling a new prescription for a sodium-glucose cotransporter-2 (SGLT-2) inhibitor or a glucagon-like peptide-1 (GLP-1) receptor agonist included older age, Black race, male sex, certain comorbid conditions, and having a primary care clinician prescribe the drug, a study found.
https://diabetes.acponline.org/archives/2022/02/11/2.htm
11 Feb 2022
Metformin use during pregnancy not associated with adverse outcomes in children
A industry-conducted cohort study in Finland found that childhood obesity, hypoglycemia, hyperglycemia, diabetes, and challenges in motor-social development did not appear to be associated with in utero exposure to metformin or metformin and insulin versus insulin alone.
https://diabetes.acponline.org/archives/2022/01/14/3.htm
14 Jan 2022